We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The S&P 500 has been hovering around the all-time high currently. Solid U.S. economic data points, easy monetary and fiscal policies and vaccine distribution led to this upsurge. The index is up 19.7% this year and 30.6% past year.
In the last 10 years, the SPDR S&P 500 (SPY) ETF gained a 15.23% compound annual return, with a 13.45% standard deviation. Tech stocks were mainly responsible for the S&P 500’s monumental achievement.
The S&P 500 currently puts 27.80% of the fund in Information Technology. Apple (6.17%), Microsoft (5.99%) and Amazon (3.66%) are its top three holdings. About 26.54% of the fund is held in the top-10 section, out of which more than 20% goes to Information Technology.
For the 466 S&P 500 members that have reported Q2 results already this reporting season, total earnings are up 97.8% on 25.8% higher revenues, with 86.9% beating EPS estimates and 86.9% topping revenue estimates, per Zacks Earnings Trends issued on Aug 18, 2021.
The healthcare sector holds 13.73% of the fund. The sector is defensive in nature. Amid the ongoing health emergency, no one can ignore the necessity of this sector, let alone the sector’s durability amid the growing need for medication and treatments for other critical diseases.
In particular, renewed optimism over the global economic recovery after the first full U.S. approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech bolstered risk-on trade. This is because the full approval will help mitigate the ongoing surge in the COVID-19 Delta variant and lead to a continued reopening of the economy.
Hence, investors can play S&P 500 ETFs like SPY, Vanguard S&P 500 ETF (VOO - Free Report) , iShares Core S&P 500 ETF (IVV - Free Report) , S&P 500 growth ETF (SPYG - Free Report) , S&P 500 value ETF (SPYV - Free Report) , SPDR Portfolio S&P 500 High Dividend ETF Fund (SPYD) and leveraged S&P 500 ETFs like Direxion Daily S&P 500 Bull 3X Shares (SPXL), ProShares Ultra S&P500 (SSO) and ProShares UltraPro S&P500 (UPRO - Free Report) .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why to Tap S&P 500 ETFs Right Now
The S&P 500 has been hovering around the all-time high currently. Solid U.S. economic data points, easy monetary and fiscal policies and vaccine distribution led to this upsurge. The index is up 19.7% this year and 30.6% past year.
In the last 10 years, the SPDR S&P 500 (SPY) ETF gained a 15.23% compound annual return, with a 13.45% standard deviation. Tech stocks were mainly responsible for the S&P 500’s monumental achievement.
The S&P 500 currently puts 27.80% of the fund in Information Technology. Apple (6.17%), Microsoft (5.99%) and Amazon (3.66%) are its top three holdings. About 26.54% of the fund is held in the top-10 section, out of which more than 20% goes to Information Technology.
For the 466 S&P 500 members that have reported Q2 results already this reporting season, total earnings are up 97.8% on 25.8% higher revenues, with 86.9% beating EPS estimates and 86.9% topping revenue estimates, per Zacks Earnings Trends issued on Aug 18, 2021.
The healthcare sector holds 13.73% of the fund. The sector is defensive in nature. Amid the ongoing health emergency, no one can ignore the necessity of this sector, let alone the sector’s durability amid the growing need for medication and treatments for other critical diseases.
In particular, renewed optimism over the global economic recovery after the first full U.S. approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech bolstered risk-on trade. This is because the full approval will help mitigate the ongoing surge in the COVID-19 Delta variant and lead to a continued reopening of the economy.
Hence, investors can play S&P 500 ETFs like SPY, Vanguard S&P 500 ETF (VOO - Free Report) , iShares Core S&P 500 ETF (IVV - Free Report) , S&P 500 growth ETF (SPYG - Free Report) , S&P 500 value ETF (SPYV - Free Report) , SPDR Portfolio S&P 500 High Dividend ETF Fund (SPYD) and leveraged S&P 500 ETFs like Direxion Daily S&P 500 Bull 3X Shares (SPXL), ProShares Ultra S&P500 (SSO) and ProShares UltraPro S&P500 (UPRO - Free Report) .